The University of Chicago Header Logo

Connection

Michael Davidson to Psoriasis

Back to Details
This is a "connection" page, showing publications Michael Davidson has written about Psoriasis.
Michael Davidson
Connection Strength
0.172
Psoriasis
  1. Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial. Cardiovasc Res. 2024 05 29; 120(7):678-680.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.